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Abstract An endophyte is a fungus or bacterium that lives within a plant in a symbiotic relationship. Extensive colo-
nization of the plant tissue by endophytes creates a barrier effect, where they outcompete and prevent pathogenic
organisms from taking hold. This happens by producing secondary metabolites that inhibit the growth of the competitors or
pathogens. In this way they play a very important role in the plant defence mechanisms. The metabolites produced by these
endophytes fall within a wide range of classes of compounds that include peptides which are the focus of this review.
Peptides are increasingly being selected for drug development because they are specific for their targets and have a higher
degree of interactions. There have been quite a number of endophytic peptides reported in the recent past indicating that
endophytes can be used for the production of peptide based drugs. Molecular screening for NRPS, which shows peptide
producing capability, has also shown that endophytes are potential producers of peptides. The presence of NRPS also offers
the possibility of genetic modifications which may generate peptides with high pharmacological activities. This review,
therefore, aims to show the current status of peptides isolated from endophytic bacteria and fungi in the recent decade.
Endophytes as potential sources of peptides according to NRPS studies will also be discussed.
Keywords Peptides  Endophytes  NRPS  Bioactivities  Genetic engineering
1 Introduction
An endophyte which is predominantly a bacterium or
fungus has an endosymbiotic relationship with the plant
host [1, 2]. Endosymbiosis can be defined as a type of
symbiosis in which one organism lives inside the other
each benefiting from the relationship [3, 4]. Although
endophytes were found in all studied plant species, the
endophyte/host plant relationship is not yet well under-
stood [5–7]. This may involve competition among endo-
phytic species in the host tissue interposed by production of
antifungal metabolites and detoxification of such inhibitors
produced by endophytes [8]. Although mycorrhizal fungi
colonize plant roots and reside into the rhizosphere,
endophytes live entirely within plant tissues and may
develop within roots, stems and leaves, sporulate at plant or
host-tissue senescence [9–11].
1.1 What Do Endophytes Do?
Endophytes can cooperate with their host plant by producing
secondary metabolites that can protect the plant providing
the ability to defend against predators, help their hosts to
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adapt in different stress conditions for survival [12–14]. It
has been reported that the occurrence of a mutualistic
endophyte works as a ‘‘biological trigger’’ to stimulate the
stress response system more efficiently than nonmutualistic
plants [15]. Endophytes encourage plant growth in different
ways, such as production of siderophores e.g. enterobactin
[16], and plant growth regulators such as indole-acetic acid
[17], they can also enhance plant growth through phosphate
solubilizing activity [18]. Moreover, endophytic bacteria
supply essential vitamins to plants [19].
1.2 Ethnobotanical Approach
One of the efficient methodologies used to find interesting
endophytic strains is to take an ethnobotanical approach. In
this case the knowledge of native people who have relied
on plants as medicines for centuries must be followed [20].
Traditional herbal medicines in developing countries play
an important role in improving the health status of the
population and preventing endemic and acute diseases [21].
Also in developed countries traditional herbal medicine has
attracted great interest, reinforced by the green movements
and an increasing aversion to synthetic materials [22].
Traditional Chinese medicinal plants are the most famous
example. They are sources of biologically active com-
pounds, providing raw materials for the pharmaceutical
industry for more than 5000 years.
It is interesting to note the story of the peptides munum-
bicins, which are isolated from snakevine Kennedia nigris-
cans. This plant was discovered several years ago by a tribal
leader, Reggie Munumbie as a medicinal source in Aborig-
inal Australians culture to treat open, bleeding wounds to
preclude sepsis. From this plant the endophytic Streptomyces
NRRL 3052 generated a series of wide-spectrum peptides
known as munumbicins. Recently, at least 39 different
Streptomyces spp. were delivered from several snakevine
plants collected in various places in the Northern Territory,
Australia [23, 24]. These findings confirmed that the world’s
rainforests are a novel source of endophytic streptomycetes.
1.3 Isolation of Endophytes
Although vacuum or pressure extraction technique was
successfully used to isolate endophytic bacteria from
grapevine [25], and citrus trees [26], however, the method
needs woody stems, because softer plant materials will col-
lapse under vacuum. Another technique suggested the
extraction of plant sap by using a Scholander pressure bomb
[27]. The most known and standard isolation procedure is the
surface sterilization followed by plating of small sterilized
piece of plant material onto nutrient agar [28, 29]. Regarding
the surface sterilization technique, the collected plant must
be processed immediately after collection. The plant parts,
which could be leaves, steams, seeds and roots, should be cut
into small pieces, in order to facilitate both surface sterili-
zation and the isolation [30]. Surface sterilization steps are
normally performed to ensure the elimination of surface
microorganisms. Surface sterilization of plant segments
normally involves treating the plant material with a strong
oxidant or general disinfectant shortly, followed by a sterile
rinse to remove residual sterilant. Sodium hypochlorite
(NaOCl), diluted in water to concentrations of 2–10 %, is the
most known surface sterilant. The most commonly used
wetting agent is ethanol (70–95 %); since it has limited
antibiotic activity. At the end segments are rinsed in sterile
water or 70–95 % ethanol after treatment for 1 min to
remove the sterilant [11]. Sterilized segments are plated onto
malt extract or potato dextrose agar and nutrient agar, which
are commonly used for fungi and bacteria respectively.
Colony-limiting agents and antibiotics also are often used for
primary isolations. Since pure colonies of either fungus or
bacterium are isolated, further characterization and taxo-
nomical steps should be performed.
1.4 Historical Background
As plants and microorganisms form close communities and
as there is an increasing overlap between metabolites from
microbes and plants; bacteria or fungi can produce secondary
metabolites also inside the host plant. And indeed, some of
the metabolites isolated from plant sources trace their origin
back to endophytic microbes within the plants [31] (Fig. 1).
The production of bioactive metabolites by endophytes
might be connected to the independent development of these
microorganisms. They may have combined genetic infor-
mation from higher plants, which trigger them to adapt to the
host and obtain defense functions such as protection from
pathogens, insects, and grazing animals [32, 33]. Such cases,
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Fig. 1 Metabolites of endophytes are overlapping between medicinal
plants and microbes
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the same compound develops independently in plants and
their microbial endophytes [34].
The most fascinating endophytic fungus is Acremonium
sp. of the European yew (Taxus baccata). It yields a series of
antifungal-anticancer peptides known as the leucinostatins;
the most important of which is leucinostatin A, which
demonstrated antifungal activity against the oomycetous
plant-pathogenic fungus Pythium ultimum with an effective
1 day 50 % inhibitory concentration of \1 lmol. It also
exihibits activity against certain human cancer cell lines, for
instance, its IC50 value is 2.3 nM for breast cancer cell line
BT-20 contrasted with 640 nM for a normal mammary cell
line [35]. The lipopetide echinocandin A (from endophytic
fungi Cryptosporiopsis sp. and Pezicula sp.) [36] and other
echinocandins represent the first new antifungal class
introduced for more than 25 years [37, 38]. They inhibit the
synthesis of 1,3-b-D-glucan, an essential component of the
fungal cell wall, and represents a valuable treatment option
for fungal infections. They demonstrate potent in vitro and
in vivo fungicidal activity against Candida species [39].
Cryptocandin (from endophytic fungus Cryptosporiopsis
quercina) [40] is an antimycotic drug against multiple
human pathogens including C. albicans and Histoplasma
capsulatum (causal agent of the lung disease Histoplasmo-
sis), in addition to T. rubrum and T. mentagrophytes [41]. Its
most important activity is the inhibition of the growth of a
number of phytopathogenic fungi including Sclerotinia
sclerotiorum, the fungus that causes white mold disease and
affects over 400 plants species, and Botrytis cinerea, a





























































A number of lipopeptide antimycotics are produced by
endophytic bacteria Pseudomonas syringae and related
species, such as syringomycins A1, E and G [43] and
pseudomycins, exhibit broad-spectrum of antifungal
activity [44, 45]. Ecomycins are a novel family of peptide
antimycotics, isolated in 1997 from Pseudomonas viridif-
lava, a plant-associated bacterium; they have significant
bioactivities against a wide range of human and plant
pathogenic fungi. The minimum inhibitory concentration
values for ecomycin B are 4.0 lg mL-1 against Crypto-
coccus neoformans and and 31 lg mL-1 against Candida
albicans [46]. Pseudomonas viridiflava is an endophytic
bacterium and is associated with the leaves of lettuce
(Lactuca sativa) and many grass species.
2 Recently Discovered Endophytic Peptides
This section describes endophytic peptides isolated in the
last decade. The number of the isolated endophytic pep-
tides was limited compared to other groups of natural
products, such as polyketides from endophytic origin. On
the other hand we observed that there are no differences
concerning peptide structures isolated from endophytic and
non endophtyic microorganisms. The endophytic peptides
have the same amino acids, which can be found in the non
endophytic bacteria and fungi. That means the endophytes
used the same biosynthetic machinery, which are used by
the non endophytes to produce peptides.
Two cyclotetrapeptides designated as cyclo-(L-Val-L-
Leu-L-Val-L-Leu) and cyclo-(L-Leu-L-Ala-L-Leu-L-Ala)
were isolated from the endophytic fungus (No. 2221) iso-
lated from Castaniopsis fissa [47, 48].
The chemical characterization of the endophytic fungus
Talaromyces wortmannii, isolated from Aloe vera, obtained
two new cyclic peptides, talaromins A and B. Their
structures were established on the basis of extensive NMR
spectroscopic and mass spectrometric analysis [49].
Cyclo-(L-Val-L-Leu-L-Val-L-Leu) Cyclo-(L-Leu-L-Ala-L-Leu-L-Ala)




















Talaromin A   R = H
Talaromin B    R = CH3
Lane and coworkers identified a number of genes
encoding non-ribosomal peptide synthetases (NRPSs) in
mutualistic grass endophyte Epichloe¨ festucae, and puta-
tively encoding a ferrichrome siderophore-synthesizing
NRPS [50, 51]. A non-ribosomal peptide synthetase gene
(sidN) was characterized. A novel extracellular siderophore
was elucidated as epichloe¨nin A and found to be the major
product of the SidN enzyme complex [52, 53]. Addition-
ally, epichloe¨nin B was identified as a triglycine variant
along with epichloe¨amide and ferriepichloe¨nin A in gut-
tation fluid from ryegrass (Lolium perenne) plants infected
with wild-type E. festucae and also detected at trace levels
in wild-type E. festucae fungal culture.
The nutritional iron sources for Herbaspirillum seroped-
icae were the first structurally described serobactin A, B and
C siderophores produced by endophytic bacteria [54].
Serobactin A n = 1 
Serobactin B
Serobactin C
 n = 2 
 n = 3 
Siderophores are small high affinity chelating molecules
with masses below 2000 Da secreted by microorganisms
[55]. Iron is a requisite nutrient for the growth and prolifer-
ation of bacteria and fungi. The most important property of
siderophores is their high affinity for the ferric ion [56, 57].
Therefore, their main role is to provide the cell with nutri-
tional iron [58, 59]. The production of siderophores is
widespread among bacteria and fungi and is found even in
higher plants. The structures of siderophores can differ
depending on the major Fe3? ligands in bacteria and fungi,
which can be catecholates, hydroxamic acids, and a-hy-
droxycarboxylic acids [60]. According to the biosynthetic
pathways, siderophores are classified as non-ribosomal
peptide synthetases (NRPS)-dependent or NRPS-indepen-
dent [61].
2.1 Endophytic Peptides Designated as Anticancer
Compounds
More than 60 % of the anticancer drugs currently in clin-
ical use are natural products or natural product derivatives
[62, 63]. The first study of the endophytic microorganism
Bacillus amyloliquefaciens sp. isolated from the medicinal
plant Ophiopogon japonicas afforded the discovery of
antitumor exopolysaccharides derived from the genus
Bacillus. These findings provide a promising natural
product source with high therapeutic value for antitumor
activity against gastric carcinoma cell lines, thereby
establishing the development of new anticancer agents
from endophytic microbes [64].
The endophytic fungus strain (No. 2524) was growing
on Avicennia marina (Forsk.) Vierh. seeds collected in a
Hong Kong mangrove delivered two new cyclic penta-
peptides, cyclo-(L-Phe-L-Leu1-L-Leu2-L-Leu3-L-Ile) and
cyclo-(Phe-Val-Leu–Leu-Leu). Cyclo-(L-Phe-L-Leu1-L-
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against the human cancer cell line Bel-7402. Cellular via-
bility was 67 % at a dose of 15 lg mL-1, whereas no dose-
related effects were detected for dosages between 15 and
500 lg mL-1 [65, 66].
In the course of screening of endophytic fungi, two
cyclic lipopeptides, fusaristatins A and B were isolated
from rice cultures of a Fusarium sp. YG-45. Fusaristatin B
exihibited a moderate inhibitory effect on topoisomerases I
(IC50: 73 lM) and II (IC50: 98 lM) without cleavable
complexes. Moreover, fusaristatins A and B demonstrated
the growth-inhibitory activity toward lung cancer cells LU



























Fusaristatin A Fusaristatin B
Depsipeptides, 1962A and 1962B, were isolated from
the fermentation broth of the mangrove endophytic fungus
(No. 1962) isolated from an old leaf of Kandelia candel
collected in Hong Kong. Their structures were established
to be 1962A, cyclo-(D-Leu-Gly-L-Tyr-L-Val-Gly-S–O-
Leu), and 1962B, cyclo-(D-Leu-Gly-L-Phe-L-Val-Gly-S–
O-Leu), respectively. Both of these recently isolated cyclo-
depsipeptides have one D-amino acid. In the MTT bioassay,










































1962 A 1962 B
A cytotoxic pullularins E and F were characterized
recently from the endophytic fungus Bionectria ochroleuca
[69].
Pullularin E Pullularin F
Cycloaspeptide A was isolated for the first time from the
endophytic fungus Penicillium janczewskii K. M. Zalessky
isolated from the phloem of the Chilean gymnosperm
Prumnopitys andina. It demonstrated low cytotoxicity















2.2 Antibacterial Endophytic Peptides
The search for novel structures from microorganisms has
increased in the last four decades [71]. While, there is an
urgent necessity for new antibacterial compounds as well
as treatment strategies, to conquer the increased difficulty
in controlling bacterial infections and levels of antibiotic
resistance of the pathogenic strains [72]. Currently, the
antimicrobial membrane-active peptides produced by
microorganisms have great interest and are important tar-
gets of intensive investigations globally [73].
Analysis of the transcriptomic PD library of the endo-
phytic Fusarium tricinctum from a shrub Rhododendron
tomentosum provided an antimicrobial peptide named Trte-
sin. The expression of Trtesin transcripts was C1000 fold
higher in the mRNA library originating from PDB-grown
fungi and demonstrating high antimicrobial activity. Trtesin
was cloned, expressed, and purified in pET32 and it consisted
of 52 amino acids with 6 cysteine molecules. The molecular
weight of Trtesin is 6138.92 Da. An additional N-terminal
sequencing was performed to confirm the intact peptide, as
well as to check the correct amino acid sequence. The MIC of
Trtesin was determined against several bacteria as 64 lg/
Cyclo-(L-Phe-L-Leu1-LLeu2-L-Leu3 -L-Ile) Cyclo-(Phe-Val-Leu-Leu-Leu)
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mL. Moreover the peptide demonstrated a mild activity
against F. oxysporum in agar diffusion assay, as a zone of
inhibition of 10 mm at 100 lg of the peptide [74].
Paenibacillus sp. strain Aloe-11, a Gram-positive bacte-
ria isolated from the root of Aloe chinensis in the southwest
region of China. The strain exhibited fascinating antibiotic
activity and intestine colonization ability. Several giant
nonribosomal peptide synthetase (NRPS) genes were iden-
tified in the genome of Paenibacillus sp. strain Aloe-11,
which are involved in the biosynthesis of antibiotics such as
fusaricidin [75] and bacitracin [76] and other unknown
peptides. It is important to mention that bacitracin antibiotic
disrupts both gram positive and gram negative bacteria by
interfering with cell wall and peptidoglycan synthesis.
Antibacterial cyclo-(Pro-Thr) and cyclo-(Pro-Tyr) were
produced by the fermentation broth of endophytic fungus
Penicillium sp. isolated from the mangrove plant Acrosti-
chum aureurm. Both compounds demonstrated activity















2.3 Antifungal Endophytic Peptides
Epichlicin a novel cyclic peptide was obtained from the
endophytic fungus Epichloe typhina, of the timothy plant
(Phleum pretense L.). The amino acids were sequenced by
NMR and mass spectrometry experiments. Enantiomers of
3-amino tetradecanoic acid, the amino acid of epichlicin,
were synthesized as authentic standards. The stereochem-
istry of the amino acids was determined by means of an
advanced Marfey method and chemical manipulation.
Epichlicin exhibited inhibitory activity against the spore of
the pathogenic fungus of the timothy plant Cladosporium































Five hybrid peptide-polyketides, curvularides A–E, were
obtained from the endophytic fungus Curvularia genicu-
lata, isolated from the limbs of Catunaregam tomentosa.
Structure elucidation for curvularides A–E was performed
by analysis of spectroscopic data and single-crystal X-ray
crystallography. Curvularide B demonstrated antifungal
activity against C. albicans, and it also exhibited syner-


























Curvularide A (R = H)
Curvularide C (R = CH3)
Curvularide B
Curvularide D Curvularide E
The cryptic role of endophytic fungi as sources of novel
bioactive peptides was emphasized by Pagnozzi and her
coworkers on Trichoderma citrinoviride investigations. It
is an endophytic fungus of cork oak, which was selected
previously for its antagonistic potential against various
fungal pathogens involved in oak decline. The strain was
cultivated and a mixture of polypeptide antibiotics (pep-
taibols) belonging to the paracelsin family was identified
[80]. Purification and analyses of the peptide mixture
afforded seven new amino acid sequences. The peptide
mixture showed strong antifungal activity toward seven
important forest tree pathogens, and it was highly toxic in
an Artemia salina (brine shrimp) bioassay [81]. It is
important to note that peptaibols and peptaibiotics are a
class of linear peptides having a high alpha-aminoisobu-
tyric acid (Aib) content and produced by filamentous fungi,
especially by the members of the genus Trichoderma.
These antibiotics are economically important for their anti-
microbial and anti-cancer properties as well as ability to
induce systemic resistance in plants against microbial
violation [82, 83]. A peptide collutellin A exhibited anti-
fungal activity against plant pathogenic fungi Botrytis
cinerea and Sclerotinia sclerotiorum with a MIC of
3.6 lg mL-1 after 48 h [84].
2.4 Endophytic Peptides are Immunosuppressive Drugs
Several non-ribosomal peptides received attention due to
their pharmaceutical importance as antibiotics or immu-
nosuppressive drugs [85, 86]. Reported literature about
Colletotrichum species isolated from medicinal plants
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afforded an immunosuppressive novel peptide collutellin A
along with wide range of biologically active natural
metabolites including activity of cancer cell lines [84].
Two new cyclodepsipeptides called trichomides A and
B, respectively, were isolated recently from the endophytic
fungus Trichothecium roseum. Trichomide A has immu-
nosuppressive effect more selectively than cyclosporine A.
It was found that trichomide A decreases the expression of
Bcl-2, increases the expression of Bax, and has a small or
negligible effect on the expressions of p-Akt, CD25, and
CD69 [87].
It is interesting to note that regarding the recent idea of
plant–microbe interactions, several mechanisms that con-
trol the endophytic immunomodulation of host plants could
be much more than that of the translocation of the effector
proteins [88]. The endophytic microbes are usually an
excellent producer of bioactive secondary metabolites [89,
90]. This knowledge along with the findings of a cross-
kingdom difference in fundamental immunities, strength-
ened collectively the hypothesis that endophytic fungi and
bacteria may be developed to produce small molecules
which have potent immunosuppressive activity to mammal
cells [91, 92].
A potential novel immunosuppressive peptide collutellin
A was isolated in 2008 from an endophytic fungus Col-
letotrichum dematium collected from a Pteromischum sp.
growing in a tropical forest in Costa Rica. In a comparison
study with cyclosporine [93], collutellin A inhibited CD4?
T cell activation of interleukin 2 (IL-2) production with an
IC50 of 167.3 ± 0.38 nM, while cyclosporin A in the same
test yielded a value of 61.8 nM. This indicated the
immunosuppressive activity of collutellin A by the inhi-
bition of IL-2 production with very low concentration.
Moreover cyclosporin A at or above 8 lg mL-1 demon-
strated high levels of cytotoxicity on human peripheral
blood mononuclear cells, in contrast collutellin A or
DMSO (carrier) alone exhibited no toxicity, after 24 and
48 h of culture. The molecular weight of collutellin A is
1127.7 Da, and its amino acid residues are Ile, Val, Ser,
N-methyl-Val and beta-aminoisobutryic acid in nominal
molar ratios of 3:2:1:1:1 respectively. Independent lines of
evidence suggest that the peptide is cyclic and sequences of
Val-Ile-Ser-Ile and Ile-Pro-Val were delivered by MS/MS
as well as Edman degradation methods.
2.5 Novel Endophytic Peptides Demonstrating
Multiple Activities
Interestingly, between 2003 and 2005 several peptides
isolated from endophytic streptomycetes. These types of
peptides exhibited numerous kinds of bioactivities such as
antibacterial, antifungal and antimalarial activities. From
our point of view the missing structures of these peptides
prevented a comparison, which can be established between
endophytic bacteria and fungi related structures. Moreover,
concerning the multiple activities of these peptides are they
depending on the presence of some special amino acids?
For example un natural amino acids such as beta-amin-
oisobutryic were emerged as very promising tools in
medicinal chemistry. Unfortunately, the questions will
remain till those structures publish.
In 2003 Strobel and coworkers isolated the peptides
kakadumycins from an endophytic streptomycete (NRRL
30566) isolated from a fern-leaved grevillea (Grevillea
pteridifolia) tree in the Northern Territory of Australia
[94]. Kakadumycin A was the main product and it was
structurally related to a quinoxaline antibiotic, echinomy-
cin [95, 96]. Kakadumycin A displayed better bioactivity
than echinomycin. It demonstrated antibacterial activity
against Gram-positive bacteria, especially against Bacillus
anthracis strains, the minimum inhibitory concentrations
are 0.2–0.3 lg mL-1 and 1.0–1.2 lg mL-1 for kakadu-
mycin A and echinomycin respectively. Both echinomycin
and kakadumycin A exhibited antimalarial activity against
Plasmodium falciparum with LD50s in the range of
7–10 ng mL-1. In macromolecular synthesis assays both
kakadumycin A and echinomycin displayed the same































Coronamycin is a complex of novel peptide antibiotics
isolated by Strobel and coworkers in 2004. Coronamycin is
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an epiphytic vine, Monstera sp., which was found in the
Manu region of the upper Amazon of Peru [97]. It showed
activity against pythiaceous fungi and a human pathogenic
fungus Cryptococcus neoformans. It displayed activity
against Plasmodium falciparum, with an IC50 of
9.0 ng mL-1. The cytotoxicity of coronamycin against a
primary mammary epithelial cell line (HMEC) delivered an
IC50 of 5–10 mg mL
-1, whereas taxol yielded a value of
30–40 mg mL-1. To our knowledge the structures of cor-
onamycins are still not yet published, their molecular weight
are 1217.9 and 1203.8 Da and a search in the Dictionary of
Chapmann and Hall [98] previously showed no similarity
with all present peptides. The closest chemical relative of
coronamycin could be a cyclic peptide polymyxin B1, pro-
duced by Bacillus polymyxa, which has a mass of 1203 Da,
but contains leucine, but not tryrosine or methionine. Coro-
namycin peptides could be new class of antibiotics.
In 2005 the same group of Strobel and coworkers discov-
ered two novel peptides munumbicins E-4 and E-5 from an
endophytic Streptomyces NRRL 30562, which was originally
isolated from Kennedia nigriscans, snakevine, in the Northern
Territory of Australia [99]. The plant was used for centuries by
Aboriginal peoples to treat open bleeding wounds to prevent
sepsis. Previously, the same endophytic bacteria afforded
munumbicins A and B [100]. Munumbicins E-4 and E-5
exhibited antibacterial activity against gram-positive and
gram-negative bacteria and antifungal activity against the
plant pathogenic fungus, Pythium ultimum at 5.0 mg mL-1.
In addition to antimalarial activity against Plasmodium fal-
ciparum with IC50 values of 0.50 ± 0.08 and
0.87 ± 0.0.26 mg mL-1 for E-4 and E-5, respectively. It is
important to mention that the exact structures of E-4 and E-5
have not been published. Both peptide antibiotics have iden-
tical molecular weight (1445.00) but different retention times
on HPLC. They considered as chromophoric peptides whose
structures are uniquely different from the actinomycins.
3 Endophytes as Potential Producers of Peptides
Nonribosomal peptide synthetases (NRPSs) a large data-
base of novel NRPS gene sequences are present in
microbial genomes and metagenomes [101]. They are large
multimodular biocatalysts that utilize complex regiospeci-
fic and stereospecific reactions to assemble structurally and
functionally diverse peptides compared to the ribosomal
system [102]. These peptides have important medicinal
applications such as antibiotics, anticancer agents, immu-
nosuppressants, enzyme inhibitors, siderophores, herbi-
cides, antifungals, insecticides, and anthelmintics [103].
Normally, the catalytic domains of NRPS select, activate or
modify the covalently tethered reaction intermediates to
control the iterative chain elongation process and product
release, which occur during the ribosome-independent
peptide synthesis [104]. It is important to mention that one
NRPS gene cluster was discovered bearing a 30-kb DNA
fragment, containing four genes (lchAA, lchAB, lchAC, and
lchAD) involved in the biosynthesis of surface-active
lipopeptides, such as lichenysin [105, 106].
3.1 Current Molecular Screenings for NRPS
in Endophytes
Currently, molecular screening for (NRPSs) in endophytes
is being performed to assess the peptide-producing capa-
bility of isolated fungi or bacteria, which are important
natural product targets nowadays. Moreover, the presence
of NRPS could offer further genetic modifications, which
may generate novel genetically modified peptides in the
future with high pharmacological importance. In parallel,
anticancer as well as antimicrobial bioassays were obtained
for the crude extracts to determine the most active strains.
In this respect we summarized the recent data concerning
NRPSs screening in endophytes. NRPSs of unknown
function were targeted in the fungal endophytes (genera
Neotyphodium and Epichloe¨) in addition to these some
novel endophytic NRPS genes have been characterized
such as NRPS5 using a degenerate PCR screen [107].
Examples of genetic screening for NRPS and biological
activities of the endophytes were reported from Chinese
herbs. Most of the NRPS screening was afforded by Chi-
nese research groups, hence the Chinese flora is very rich
with medicinal plants, and this can be a suitable opportu-
nity to focus on endophytes isolation, bioactivities study
and screening of the NRPSs. Although the PKSs were also
screened in parallel, we preferred to concentrate on the
NRPS as an indicator of the potentiality of the isolated
endophytes to produce peptides. Endophytic Streptomy-
cetes associated with pharmaceutical plants from the
rainforest in Yunnan province, China, displayed remark-
able antitumour and antimicrobial activities. Additionally
high frequencies of positive PCR amplification were
obtained for NRPS (61.0 %) biosynthetic systems [108].
Camptotheca acuminata Decne collected from Yunnan
University afforded ninety endophytic actinomycetes. The
results of 16S rRNA gene sequences confirmed that the
isolates belonged to 10 genera and 6 families. Around
33.4 % of the endophytic actinomycete cultures demon-
strated antimicrobial activity. The non-ribosomal peptide
synthetase (NRPS) sequences were detected by PCR in
45.6 % of studied strains [109]. Tropical plants collected
from several locations in Papua New Guinea and Mbor-
okua Island, Solomon Islands afforded 123 endophytic
actinomycetes. All isolates were characterized by 16S
rRNA gene sequencing to deliver 17 different genera. Rare
genera, such as Sphaerisporangium and Planotetraspora
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were detected; they have never been previously reported to
be endophytic. About 60 % of the extracts demonstrated
bioactivity or displayed LC–MS profiles with spectra
indicative of secondary metabolites. The 29 nonproductive
strains were further investigated by the detection of puta-
tive nonribosomal peptide synthetase (NRPS) genes and all
were positive [110].
An endophytic actinomycetes strain LCB-0297 isolated
from Yew Podocarpus (Podocarpus macrophyllus) was
characterized primarily as a genus of Streptomyces. It
exhibited strong antimicrobial and anticancer activities.
PCR check-screening of its antibiotic biosynthesis genes
afforded non-ribosomal polypeptide synthetase (NRPS)
genes confirmed that its potentiality for antibiotic biosyn-
thesis genes [111]. The ethnomedical plants, Forsythia
suspensa and Solanum torvum, collected in Chengdu, China
afforded 14 Strains of endophytic actinomycetes. Ten of the
strains showed inhibition to HepG2 cancer cell line in
varied degrees, accounting for 71 % of total isolates, 3
strains exhibited antibacterial activity and one showed acute
cytotoxicity and wide-spectrum of antibacterial activities.
Based on 16S rRNA gene partial sequences, one strain was
identified to genus Kribbella, and the remaining 13 strains
belonged to genus Streptomyces. PCR screening of bio-
synthesis genes afforded 5 strains possessing NRPS genes.
Endophytic actinomycetes are known to be potential for
producing prolific bioactive compounds [112]. Panxi pla-
teau in South-west Sichuan in China with its unique geo-
graphical and climatological characteristics is a habitat to a
great variety of medicinal plants. It was reported that 560
endophytic actinomycetes were isolated from 26 medicinal
plant species in Panxi plateau. 60 isolates were selected for
16S rDNA-RFLP analysis and 14 representative strains
were chosen for 16S rDNA sequencing. According to the
phylogenetic analysis, seven isolates were Streptomyces sp.,
while the remainder belonged to genera Micromonospora,
Oerskovia, Nonomuraea, Promicromonospora and Rhodo-
coccus. Antimicrobial activity analysis combined with the
results of amplifying genes coding for nonribosomal pep-
tide synthetase (NRPS) showed that endophytic actinomy-
cetes had broad-spectrum antimicrobial activity and
potential natural product diversity [113]. The total DNA
extracts of 30 traditional Chinese herbs, which were
screened to study the potential of endophytes to produce
bioactive peptides, by the presence of NRPS genes. Six
bacterial NRPS and three fungal NRPS gene fragments
were successful identified by the four PCR screens. Ana-
lysis of the detected endophyte gene fragments afforded
consideration of the possible bioactivity of the peptides
produced by endophytes in medicinal herbs [114]. Eighteen
actinomycete isolates from 6 Stemona earthnut samples
were screened for NRPS and biological activity. It was
found that the isolates belonged to 4 genera, Streptomyces,
Pseudonocardia, Micromonospora and Methylobacterium.
The isolates also showed distinguished antibacterial activ-
ities among them 13 strains showed antimicrobial activity
against Staphylococcus aureus and/or Pseudomonas aeru-
ginosa. Seventeen isolates were positive for NRPS genes. It
was reported based on the results of study that endophytic
actinomycetes from Stemona, dominated by Streptomyces
and Micromonospora, have good secondary metabolic
potential including peptides and could act as a promising
resource for bioactive metabolite discovery in the future
[115]. A survey for endophytic fungi was carried out in 12
different regions of 7 provinces in China, delivered 2 Epi-
chloe species and 4 Neotyphodium species. An improved
method was used for genomic DNA of the slow-growing
fungal endophytes. The DNA was used as template to detect
the NRPS genes of the endophytes. The resulting sequences
afforded a high sequence similarity with the NRPS gene
[116]. Endophytes were isolated from eight different anti-
cancer plants collected in China. A functional gene-based
Table 1 Recent NRPS screening studies in endophytes
No Name of the endophyte Area Host Year Ref.
1 Neotyphodium & Epichloe¨ New Zealand Ryegrass 2007 [107]
2 Streptomycetes Yunnan province, China Chinese pharmaceutical plants 2008 [108]
3 Actinomycetes China Camptotheca acuminata Decne 2010 [109]
4 Actinomycetes New york Tropical plants 2010 [110]
5 Streptomyces China Yew Podocarpus 2011 [111]
6 Actinomycetes Chengdu, China Forsythia suspensa & Solanum torvum 2011 [112]
7 Actinomycetes Panxi plateau, China Chinese medicinal plant 2011 [113]
8 Different species of bacteria and fungi China Traditional Chinese herbs 2012 [114]
9 Actinomycete Xishuangbanna, Yunnan Province, Stemona earthnut samples 2012 [115]
10 Epichloe¨ and Neotyphodium 7 provinces, China Traditional Chinese herbs 2012 [116]
11 Different species of bacteria and fungi China Anticancer plants 2012 [117]
12 Actinobacteria China Artemisia annua 2012 [118]
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Fig. 2 Important approaches in
drug discovery
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molecular screening strategy was used to target nonribos-
omal peptide synthetase (NRPS) in endophytes, it was
found that the isolated endophytes are capable of producing
a plethora of peptides. Moreover, all of the endophytic
culture broth extracts exhibited antiproliferative effects in at
least one test assay, cytotoxic, antibacterial or antifungal
[117]. Endophytic actinobacteria were obtained from
Artemisia annua. A round 228 isolates were represented at
least 19 different genera of actinobacteria were character-
ized. Concerning the antimicrobial bioassay, many of the
isolates demonstrated activity against plant pathogens.
Screening for NRPS by high frequencies of PCR amplifi-
cation was performed and it was available in 32.5 % of the
tested isolates. The herbicidal activity indicated that 19 out
of 117 samples of fermentation broths totally inhibited the
germination of Echinochloa crusgalli [118]. The above
mentioned NRPS screening in endophytes is summarized in
Table 1.
4 Engineering of Peptides: The Future Potential Drugs
NRPS enzymes are capable of synthesizing many peptide
derivatives using just one enzyme complex. The non-
ribosomal peptides are linear, cyclic, or branched cyclic
and can be modified by glycosylation, N-methylation, or
acylation [119, 120]. Several antibiotic, anticancer and
immunosuppressive agents have been synthesized [121].
The most famous classical example is the immunosup-
pressant cyclosporine and new insecticidal inniatin deriv-
atives [122]. Generally, it was reported recently that rather
than using combinatorial chemistry to synthesize natural
products derivatives, their biosynthetic pathways can be
investigated at the genetic level. The biosynthesis of most
of these natural products is controlled by single gene
clusters. Research groups characterize these clusters and
employ genetic engineering to synthesize the native com-
pounds and their derivatives. One of most important can-
didates are non ribosomal peptides [123, 124].
Looking to the current achievements in peptides engi-
neering as a powerful tool, we can conclude that the pro-
duction of new novel peptide derivatives with
pharmaceutical applications could be generated in vitro and
in vivo using the NRPS [122, 125]. It has been reported
previously of novel analogs of fungal cyclooligomer dep-
sipeptide synthetase, which were obtained by a variety of
combinatorial biosynthetic methods, including precursor-
directed biosynthesis, mutasynthesis, combinatorial muta-
synthesis, and total biosynthesis [17]. Recently, seven new
beauvericin derivatives synthesized using the nonribosomal
peptide synthetase BbBEAS from the entomopathogenic
fungus Beauveria bassiana were discovered. Chemical
diversity was generated by in vitro chemoenzymatic and
in vivo whole cell biocatalytic syntheses using either a B.
bassiana mutant or an E. coli strain expressing the bbBeas
gene [126].
Peptides are giving rise to a push in chemodiversity
approaches, which could be a fascinating route to novel
medicinally and agriculturally important therapeutic agents
for management of human and plant health [127, 128].
With rise in cancer patients and metabolic diseases like
diabetes, large pharmaceutical and biotechnological com-
panies are actively investing in the development of newer
peptides for various applications and are also opting for
newer technologies for the synthesis of peptides. A direc-
tion in peptide generation has been assessed, since cancer
chemotherapy is facing major challenges due to its inability
to deliver the correct amount of drug directly. In addition,
it affects the normal cells in the body.
Looking to the longer term, we can speculate that
methods of production and generation of peptide-based
drugs will be more common in the future and considering
the history of drug discovery, we can say that classical
natural products and small compounds will be replaced by
peptides generated by means of a combination of combi-
natorial biosynthesis, sophisticated genomic, proteomic
and transcriptomic methodologies. The era of peptides and
proteins as potential is already here before the expected
2020s (Fig. 2) [129–132].
5 Conclusion
In conclusion, peptides will play a very important role in
drug development as microbes increasingly show resis-
tance to the current classes of antibiotics. The use of NRPS
studies will also play a crucial role in the preparation of
peptide based drugs because endophytes with the potential
to produce peptides will be easily identified. Since endo-
phytes from many parts of the world has not been studied,
there is need to screen them using NRPS studies in order to
create a database of these peptide producing microorgan-
isms. Some of them may not produce peptides because
their NRPS gene clusters are silent but a higher percentage
will definitely be successful in peptide production. The
research community should, therefore, focus their efforts
on the biosynthetic mechanisms used by the non-ribosomal
peptide synthetases of endophytes, which could lead to
optimization of the production of peptides for biotechno-
logical and pharmacological studies.
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